D-0070-2022 Class III Terminated
FDA drug recall D-0070-2022 was initiated by Ultra Seal Corporation on Oct 13, 2021 and is designated Class III. Reason for recall: Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid. The recall status is terminated (terminated Mar 28, 2022). Affected quantity: 2,484,274 tablets.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 3, 2021
- Initiation Date
- Oct 13, 2021
- Termination Date
- Mar 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,484,274 tablets
Product description
PainAway II (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets , 2 tablets/pk, packaged in 12,000 Packets/Case, Material # 11161, Mfg. for Respond Industries First Aid, Mason, OH 45040 (Shipping Label)
Reason for recall
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Distribution pattern
Nationwide in the USA.
Code information
Lot #: AK-9336, exp. date 21-Oct; K9406, AK-9407, exp. date 21-Dec; K-9860, exp. date 22-Oct; AK-1057, exp. date 23-Feb
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0070-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026